Pancragen

Pancragen is a bioactive synthetic peptide composed of four amino acids.

 

 

এসকেইউ: 198869 শ্রেণী:
আপনার ভালবাসা শেয়ার করুন

Pancragen is a bioactive synthetic peptide composed of four amino acids.

Research into pancreatic function led scientists to discover a hormone-like active component within pancreatic extracts; stimulating the pancreas itself being the primary observed effect.

The exact composition of this hormone was initially unclear.

Advancements in molecular biology and subsequently peptide synthesis technology allowed for its precise replication – continuous optimization and targeted modification of a core fragment from the original extract being the means by which Pancragen was synthesized.

Post-synthesis, significant clinical research value was attributed to it.

Enhancing pancreatic tissue stability, promoting repair, and regulating metabolic homeostasis are its well documented primary benefits.

Broad প্রদাহ বিরোধী and protective effects are also seen within the liver, kidneys, nervous system and other organs.

সিকোয়েন্স

H2N-Lys-Glu-Asp-Trp-OH

CAS নম্বর

/

আণবিক সূত্র

C26H36N6O9

আণবিক ওজন

576.607

Research Of Pancragen Peptide

1.Protection and Regeneration of Pancreatic β-Cells

Depletion of these cells is the core pathological factor in ডায়াবেটিস.

Mimicking endogenous growth factors or survival signals, inhibition of apoptosis is a key mechanism; protecting (অন্তত অস্থায়ীভাবে) beta cells and creating a supportive microenvironment for cell regeneration.

Stable blood glucose levels are maintained, indirectly through improved peripheral tissue ইনসুলিন সংবেদনশীলতা – reducing various aspects of insulin resistance and enhancing মাইটোকন্ড্রিয়াল ফাংশন.

Pancragen activates those previously mentioned survival pathways (PI3K/অ্যাক্ট এবং MAPK/ERK).

Initiating apoptotic pathways under an inflammatory attack is successfully inhibited.

Clinical trials are currently investigating true cellular regeneration as an end point.

Stimulating division and proliferation of at least some cells, combined with the earlier mentioned microenvironment, represents a fundamental reversal of diabetes progression.

2.Metabolic Regulation (as above)

Systemic improvement of insulin sensitivity is seen in animal models.

Cytoprotection reduces hepatic and চর্বিযুক্ত টিস্যু দীর্ঘস্থায়ী প্রদাহ.

Direct and indirect effects on insulin receptor and transporter activity are all part of the overall improvement in insulin sensitivity.

Antioxidant and anti-inflammatory effects of Pancragen are of significant research value.

Neuropathy and বিপাকীয় সিন্ড্রোম type damage, or any disease related to অক্সিডেটিভ স্ট্রেস, can and should benefit from Pancragen therapeutic applications.

সিওএ

এইচপিএলসি

এমএস

(1) খাভিনসন, ভি.; Durnova, ক. ও.; পলিয়াকোভা, ভি. ও.; Tolibova, জি. এইচ.; লিঙ্ক, এন. এস.; Kvetnoy, আমি. এম.; Kvetnaia, টি. ভি.; তারনোভস্কায়া, এস. আমি. Effects of pancragen on the differentiation of pancreatic cells during their ageing. Bull Exp Biol Med 2013, 154 (4), 501-504. DOI: 10.1007/s10517-013-1987-6 From NLM Medline.

(2) খাভিনসন, ভি.; গাভরিশেভা, এন. ক.; মালির, ভি. ভি.; Chefu, এস. জি.; ট্রফিমভ, ই. এল. Effect of pancragen on blood glucose level, capillary permeability and adhesion in rats with experimental diabetes mellitus. Bull Exp Biol Med 2007, 144 (4), 559-562. DOI: 10.1007/s10517-007-0377-3 From NLM Medline.

(3) খাভিনসন, ভি.; লিঙ্ক, এন. এস.; পলিয়াকোভা, ভি. ও.; Kheifets, ও. ভি.; তারনোভস্কায়া, এস. আমি; Kvetnoy, আমি. এম. Peptides tissue-specifically stimulate cell differentiation during their aging. Bull Exp Biol Med 2012, 153 (1), 148-151. DOI: 10.1007/s10517-012-1664-1 From NLM Medline.

(4) Korkushko, ও. ভি.; খাভিনসন, ভি.; Shatilo, ভি. খ.; Antonyk-Sheglova, আমি. ক.; Bondarenko, ই. ভি. Prospects of using pancragen for correction of metabolic disorders in elderly people. Bull Exp Biol Med 2011, 151 (4), 454-456. DOI: 10.1007/s10517-011-1354-4 From NLM Medline.

সিকোয়েন্স:

H2N-Lys-Glu-Asp-Trp-OH

সিএএস:

/

M.W:

576.607 g/mol

বাড়ি অনুসন্ধান করুন হোয়াটসঅ্যাপ সেবা পণ্য